Skin conditions (dermatitis, eczema, psoriasis) decisions — 2024

The Board has determined that a remand is necessary to obtain updated VA treatment records, determine if the Veteran participated in toxic exposure risk activities (TERAs) during service, and schedule VA examinations for hypertension, coronary artery disease, and tinea pedis.

The Board denied the Veteran's claims for service connection for nummular eczema and costochondritis due to a lack of current diagnoses.,The Board also remanded the Veteran's claims for service connection for plantar warts and a headache disorder.

The Veteran's claims for service connection and increased ratings are remanded due to insufficient examination reports and medical opinions.

The Board granted service connection for erectile dysfunction and denied service connection for prostate disorder, sleep apnea, skin condition (dermatitis), diverticulosis, and hearing loss.,For the remaining issues, the appeal is REMANDED.

The Veteran was granted a TDIU for the period prior to August 9, 2016. For the period between August 9, 2016 and October 1, 2017, the weight of evidence did not support a finding that any other service-connected disability prevented him from securing or following substantially gainful employment.

The Veteran's claim for an initial evaluation higher than 10 percent for chronic dermatitis is being remanded due to the RO not substantially complying with the Board's prior remand instructions. The case will be readjudicated after obtaining additional medical opinions and considering all relevant evidence.

The Veteran's initial compensable rating for pseudofolliculitis barbae from November 3, 2010, to August 13, 2021, and a rating in excess of 30 percent since August 14, 2021, are both denied.

The Board has remanded the case due to insufficient evidence regarding the Veteran's service connection for pseudofolliculitis barbae, including his active duty and prior ACDUTRA.

The Veteran's claim for service connection for tinea pedis with onychomycosis and a residual scar was denied as the evidence did not establish that his current conditions were related to his active-duty service.

The Veteran's tinea unguium condition has worsened since his last VA examination, and a new examination is needed to determine the current severity of the disability.

The Board has remanded the issues of service connection for peripheral neuropathy, chloracne, rosacea, and tinea unguium due to herbicide exposure. The Veteran's claims are now pending before the AOJ for further development.

The Board has determined that the RO did not substantially comply with the September 2022 remand directives and thus, a remand for corrective actions is required.

The Board denied service connection for a skin disorder and conjunctivitis, finding that the Veteran's current conditions were not incurred or aggravated by his military service.

The Veteran's pseudofolliculitis barbae has involved less than 5 percent of the entire body and less than 5 percent of exposed areas, requiring no therapy over the past 12 months. The Board finds that the disability does not warrant a compensable rating.

The Veteran's claim for service connection for PTSD is granted. The Veteran's tinnitus is currently rated at the maximum allowable rating of 10%. For sinusitis, rhinitis, and migraine headaches prior to May 27, 2020, a higher rating is not warranted as they are already assigned the highest schedular ratings available.

The Board has denied service connection for Pseudofolliculitis Barbae (PFB) as there is no current diagnosis of the condition.,Service connection for Thoracic Spine Arthritis and Unspecified Depressive Disorder have also been denied due to a lack of evidence linking these conditions to service.

The Veteran's claims for increased ratings and service connection were dismissed. The claim of service connection for PTSD was denied due to uncorroborated stressors, but the claim for bipolar disorder and other specified trauma- and stressor-related disorder was granted. The claim for heart disability (atrial fibrillation with bradycardia and coronary artery disease) resulted in a 60% rating.

The Board has determined that the Veteran should be afforded another opportunity for VA examinations to determine the nature and etiology of his claimed conditions, including bilateral hearing loss, plantar fasciitis, psoriasis, dry eye syndrome, hypertension, and psoriatic arthritis. The appeals encompass multiple issues related to service connection.

The Board has granted service connection for back disability, sleep apnea, atrial fibrillation, heart murmur, asthma, and eczema. The Veteran's conditions are found to be related to his active duty service.

The Veteran's initial evaluation for chloracne prior to October 20, 2023, is denied as the scars do not meet the criteria for a higher rating under Diagnostic Code 7800.